CORDA, The Heart Charity Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00123227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

CORA

Active Ingredients

Drugs in Phase 4 Trials (1)

deferiprone (ferriprox) (1 trial)

Drugs in Phase 3 Trials (1)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

beta-Thalassemia (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Hypertension (Phase 3)

Thalassemia (Phase 4)

Vascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2